Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Acta Dermato-Venereologica|December 16, 2011
Host defence against Candida albicans and the role of pattern-recognition receptorsGerd G Gauglitz, Helene Callenberg, Günther Weindl, et al.Dermatologie (Heidelberg, Germany)|February 20, 2026
[Complication management after hyaluronic acid filler injections : VIO classification of adverse effects]Tanja C FischerJournal of Cosmetic Dermatology|December 3, 2010
A European evaluation of cosmetic treatment of facial volume loss with Juvéderm™ Voluma™ in patients previously treated with Restylane Sub-Q™Tanja C FischerExpert Opinion on Drug Safety|July 19, 2014
Understanding the safety and tolerability of facial filling therapeuticsDaniela Kulichova, Alyona Borovaya, Thomas Ruzicka, et al.Facial Plastic Surgery : FPS|June 2, 2016
DLQI and POSAS Scores in Keloid PatientsJulian Poetschke, Markus Reinholz, Hannah Schwaiger, et al.Skin Pharmacology and Physiology|December 16, 2014
The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblastsGerd G Gauglitz, Daniela Bureik, Stephanie Zwicker, et al.MMW Fortschritte Der Medizin|May 26, 2016
[Anti-wrinkle creams with hyaluronic acid: how effective are they?]Julian Poetschke, Hannah Schwaiger, Stephanie Steckmeier, et al.Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|October 18, 2013
Treatment of striae distensae using an ablative Erbium: YAG fractional laser versus a 585-nm pulsed-dye laserGerd G Gauglitz, Markus Reinholz, Peter Kaudewitz, et al.Burns : Journal of the International Society for Burn Injuries|April 29, 2014
Up-to-date approach to manage keloids and hypertrophic scars: a useful guideAnna I Arno, Gerd G Gauglitz, Juan P Barret, et al.Current Opinion in Clinical Nutrition and Metabolic Care|December 16, 2010
Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?Gerd G Gauglitz, Felicia N Williams, David N Herndon, et al.Pageof 8